Hematology & Oncology Doctors in Roseville, CA Accepting Medicare

10 Hematology & Oncology doctors found. Showing 1 - 10

Uma H Gowda, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8 Medical Plaza Dr Ste 300, Roseville, CA 95661 Phone: 916-782-5106    Fax: 916-878-4941

Frank Tze Hsieh, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000

Sidney M. Crain, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000

Dr. Lisa Law, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-5626    Fax: 916-474-2201

Dinesh Kotak, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000

Sivakumar Reddy, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Two Medical Plaza, Ste 200, Roseville, CA 95661 Phone: 916-782-5106    Fax: 916-783-5927

Li F. Hu, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000

Julie L. Hersch, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000

Philip D. Sardar, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000

Kristie A Bobolis, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2 Medical Plaza Dr, Suite 200, Roseville, CA 95661 Phone: 916-782-5106    Fax: 916-771-3936

News Archive

China Sky One Medical submits application to perform clinical trials for two new generic drugs

China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that the Company has finished the required research for two new generic drugs for eye treatment and submitted application to the State Food and Drug Administration (SFDA) in China to perform clinical trials.

AstraZeneca and Nektar Therapeutics enter worldwide license agreement for two drug development programmes

AstraZeneca and Nektar Therapeutics announced today that they have entered into an exclusive worldwide license agreement for two drug development programmes: NKTR-118, a late stage investigational product being evaluated for the treatment of opioid-induced constipation, and the NKTR-119 programme, an early stage programme that is intended to deliver products for the treatment of pain without constipation side effects.

The Supreme Court arguments are over - what happens now?

News outlets sum up the oral arguments and preview when to expect a decision, what impact the legal review might have on politics and what other ripple effects could occur.

Johns Hopkins researchers identify protein that regulates the body's immune response to CMV

Infectious disease specialists at the Johns Hopkins Children's Center have identified a protein that regulates the body's immune response to cytomegalovirus (CMV), a common pathogen that causes lifelong infections and can lead to devastating illness in newborns and those with weakened immune systems.

More AIDS-defining illnesses and severe side effects occur with appropriate comparator therapy

​The drug combination of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil (elvitegravir fixed combination, trade name: Stribild) has been approved in Germany since May 2013 for the treatment of adults infected with human immunodeficiency virus type 1 (HIV-1).

Read more Medical News

› Verified 2 days ago